After a four-mile crawl from NASA's Vehicle Assembly Building, the Space Launch System stands ready on its launchpad in Cape Canaveral, Florida, on Aug. 17, 2022. Credit: NASA / Joel Kowsky The ...

NASA's SLS rocket is scheduled to move to the launch pad this weekend for the Artemis II mission. A launch is targeted for no earlier than February 6, but the exact date depends on upcoming tests.

Add Yahoo as a preferred source to see more of our stories on Google. NASA's next-generation moon rocket, the Space Launch System (SLS) rocket with the Orion crew capsule, rolls to the launch pad at ...

NASA's SLS rocket for the Artemis II mission rolled out to the launch pad at Kennedy Space Center. The crewed Artemis II mission will send four astronauts on a test flight around the moon. This ...

The Space Launch System rocket and Orion spacecraft make their way to Launch Complex 39B Jan. 17. Credit: SpaceNews/Jeff Foust Updated 8:15 p.m. Eastern with arrival at the launch pad. KENNEDY SPACE ...

NASA's long-awaited moonshot with astronauts is off until at least March because of leaking hydrogen fuel. The space agency ...

WASHINGTON, Jan 17 (Reuters) - NASA rolled its massive Space Launch System rocket toward its launchpad in Florida on Saturday, kicking off a final phase of preparations for the agency's Artemis II ...

NASA fueled its new moon rocket in one final make-or-break test Monday, with hopes of sending astronauts on a lunar ...

Get Greenville news and weather from WYFF News 4. Watch live weekdays at 4:30am, 5am, 5:30am, 6am, 12pm, 4pm, 5pm, 5:30pm, 6pm and 11pm. Watch live weekends at 5am, 6am, 7am, 6pm and 11pm. If you have ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

NASA’s mega moon rocket will begin a slow trek to its Florida launchpad early Saturday, marking a major milestone for Artemis II, the agency’s first crewed lunar mission in over 50 years. The rollout ...

Sellas Life Sciences faces a high bar with its Phase 3 REGAL trial for GPS in AML second remission. REGAL’s ambitious hazard ratio target, open-label design, and heterogeneous control arm raise ...